Related Experiment Video
Updated: Jul 15, 2025

07:42
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.0K
Novel Biomarkers to Guide Immunotherapy De-Escalation in the Neoadjuvant Setting in Triple-Negative Breast Cancer
1Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Journal of Personalized Medicine
|September 28, 2023
Abstract:
Triple-negative breast cancer (TNBC) has the highest incidence of disease recurrence and distant metastases among breast cancer subtypes, leading to significant rates of morbidity and mortality [...].

